BCAM
LLY icon

Boston Common Asset Management’s Eli Lilly LLY Stock Holding History

Boston Common Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28M Buy
24,195
+1,638
+7% +$1.93M 1.62% 12
2026
Q2 		$27.1M Sell
22,557
-1,796
-7% -$1.84M 1.6% 12
2026
Q1 		$22.4M Sell
24,353
-2,875
-11% -$2.91M 1.44% 14
2025
Q4 		$29.3M Sell
27,228
-8,064
-23% -$7.71M 1.76% 11
2025
Q3 		$26.9M Sell
35,292
-471
-1% -$350K 0.75% 35
2025
Q2 		$27.9M Buy
35,763
+8,468
+31% +$6.58M 0.78% 36
2025
Q1 		$22.5M Buy
27,295
+3,267
+14% +$2.72M 0.68% 46
2024
Q4 		$18.5M Buy
24,028
+5,465
+29% +$4.53M 0.54% 67
2024
Q3 		$16.4M Buy
18,563
+8,106
+78% +$7.29M 0.43% 91
2024
Q2 		$9.47M Buy
10,457
+600
+6% +$480K 0.24% 128
2024
Q1 		$7.67M Sell
9,857
-247
-2% -$176K 0.18% 155
2023
Q4 		$5.89M Sell
10,104
-287
-3% -$168K 0.13% 189
2023
Q3 		$5.58M Buy
10,391
+4,253
+69% +$2.19M 0.13% 186
2023
Q2 		$2.88M Buy
+6,138
New +$2.57M 0.06% 236
2023
Q1 		– Sell
-2,825
Closed -$1.03M – 331
2022
Q4 		$1.03M Buy
2,825
+66
+2% +$23.4K 0.05% 162
2022
Q3 		$892K Buy
2,759
+35
+1% +$11.1K 0.05% 167
2022
Q2 		$883K Buy
2,724
+233
+9% +$69.9K 0.04% 178
2022
Q1 		$713K Sell
2,491
-298
-11% -$76.7K 0.03% 189
2021
Q4 		$770K Buy
2,789
+151
+6% +$38.3K 0.03% 185
2021
Q3 		$610K Buy
2,638
+6
+0.2% +$1.48K 0.03% 198
2021
Q2 		$604K Buy
2,632
+185
+8% +$37.2K 0.03% 204
2021
Q1 		$457K Buy
2,447
+27
+1% +$5.28K 0.03% 212
2020
Q4 		$409K Buy
+2,420
New +$361K 0.03% 209

Other funds holding LLY

Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Boston Common Asset Management's LLY Position: Q3 2026 in Review

Boston Common Asset Management increased its Eli Lilly (LLY) stake by 7.3% in Q3 2026, buying an estimated $1.93M and bringing the position to 24,195 shares worth $28M. The position accounts for 1.62% of the portfolio, ranked #12.

Boston Common Asset Management first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $29.3M in Q4 2025. 577 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Boston Common Asset Management held 24,195 shares of Eli Lilly worth $28M as of Q3 2026.
  • Boston Common Asset Management bought 1,638 Eli Lilly shares in Q3 2026, an estimated $1.93M.
  • Eli Lilly made up 1.62% of Boston Common Asset Management's portfolio in Q3 2026, its #12 holding.
  • Boston Common Asset Management first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Boston Common Asset Management's Eli Lilly position peaked at $29.3M in Q4 2025.
  • 577 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Boston Common Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.